BOSTON, March 23, 2017 /3BL Media/ – Jennifer James, Smart City Solutions Lead for Black & Veatch, has been selected to serve on the Boston Advisory Board of Leading Cities. The nonprofit global network promotes sustainable and resilient Smart City solutions by encouraging diplomacy and collaboration.
Black & Veatch to bring engineering expertise to NYSERDA NY Prize project
OVERLAND PARK, Kansas, 23 March 2017 /3BL Media/ – Black & Veatch is partnering with the Buffalo Niagara Medical Campus to design and assess the financial and energy efficiency impacts of a microgrid in Buffalo, N.Y. The microgrid will provide resilient, clean energy for the 120-acre campus, long-term cost-savings and potential monetization opportunities for member institutions.
GSK included in prestigious CDP ‘A lists’ for climate and water.
Our efforts to reduce carbon emissions were acknowledged in 2016 with our inclusion in the ‘Climate A List’. CDP assessed companies globally from across 10 industry sectors; we were one of only 193 companies (9% of applicants) and seven healthcare companies to be A-listed.
Designing sustainable buildings across our global operations to minimise our environmental impact.
Our new building in Ware, UK, needs carefully controlled ambient temperature and humidity to store pharmaceutical samples. The building design makes it resilient against outdoor temperature changes, while minimising environmental impacts.
Data collection and the processing power needed to support autonomous driving are huge areas of focus for development. Companies are investing heavily in driverless technologies, evidenced by news that Intel Corp. is acquiring Mobileye, an autonomous driving technology leader whose portfolio includes machine learning, road mapping, sensors, and data analytics among other technologies.
GSK has a strong commitment to operating responsibly and playing our part in meeting some of society’s biggest healthcare challenges.
GSK is a science-led global healthcare company. Our mission is to help people do more, feel better and live longer. We do this by researching and developing medicines, vaccines and consumer healthcare products that improve people’s lives. Being commercially successful and operating responsibly allows us to improve people’s health and benefit society, as well as create value for shareholders.